Skip to main content
Clinical Trials/CTRI/2024/05/067340
CTRI/2024/05/067340
Not Yet Recruiting
Phase 2

Evaluation of The Individual and Combined Effect of Mritika Lepa and oral Ayurveda Drugs on Pain Alleviation and Modulation of Inflammatory Markers in Rheumatoid Arthritis A Pilot Clinical Study - nil

ational Institute of Ayurveda0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
ational Institute of Ayurveda
Status
Not Yet Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients aged 18 to 60 years of either sex
  • Confirmed and diagnosed cases of Rheumatoid Arthritis based on established criteria e g American College of Rheumatology/European League Against Rheumatism criteria
  • Active disease status as indicated by a Disease Activity Score DAS28 of more than or equal to 3 point 2
  • Chronic cases up to 5 years

Exclusion Criteria

  • Pregnant or lactating individuals due to potential risks associated with the treatments
  • Known contraindications or allergy to any of the study drugs contents or Mritika Lepa
  • Presence of significant comorbidities such as uncontrolled diabetes hypertension renal or hepatic impairment which may interfere with the assessment of study outcomes
  • Coexistence of other autoimmune diseases
  • e g systemic lupus erythematosus that may confound the assessment of Rheumatoid Arthritis outcomes
  • Severe joint damage or deformities that may limit accurate pain assessment or interfere with the treatment outcomes
  • Use of systemic immunosuppressive agents within the last three months prior to enrolment
  • Recent major surgery within the last three months that may impact the study outcomes
  • Participation in another clinical trial within 30 days before screening
  • Inability to comply with the study procedures or follow\-up visits

Outcomes

Primary Outcomes

Not specified

Similar Trials